Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Has This Medical Leader Hit Health Care's Biggest Jackpot?

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Medtronic  (NYSE: MDT  ) is the world's largest pure medical-device maker, but this stable stock has also impressed investors with amazing growth in 2013. Shares of the company are up more than 34% in 2013. Medtronic's a powerful player in the cardiology market and more, but this company's not just thinking in American sales -- it's thinking globally.

How big are we talking? Medtronic this week agreed to an investment with India's Apollo Hospitals Enterprise to develop a portable kidney dialysis device. It's the company's first venture into kidney dialysis, a market traditionally dominated by powers such as Fresenius Medical (NYSE: FMS  ) and others. But the real key for Medtronic and its investors is India, an emerging market rivaled by few other developing economies that could provide a new booming market in health care for decades to come.

Yet is Medtronic's investment in India a sign of more good things to come for investors? In the video below, Motley Fool contributor Dan Carroll tells you everything you need to know about Medtronic's latest big move -- and how breaking into India could be the growth catalyst to keep this medical device leader on top for the long run.

Your guide to long-term financial success
Medtronic's been one of health care's top names over the years, and this solid stock is a testament to the greatest investing strategy around the markets: Investing for the long run is the easiest route to maximizing your portfolio's potential. The Motley Fool's special free report "3 Stocks That Will Help You Retire Rich" names specific investment opportunities that could help you build long-term wealth and help you retire well. The Fool also outlines critical wealth-building strategies that every investor should know. Click here to keep reading.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2680044, ~/Articles/ArticleHandler.aspx, 10/6/2015 11:02:47 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Carroll

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Today's Market

updated Moments ago Sponsored by:
DOW 16,815.55 39.12 0.23%
S&P 500 1,982.19 -4.86 -0.24%
NASD 4,753.23 -28.03 -0.59%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/6/2015 10:46 AM
MDT $70.23 Down -0.64 -0.91%
Medtronic CAPS Rating: ****
BAX $33.21 Down -0.09 -0.27%
Baxter Internation… CAPS Rating: *****
FMS $40.22 Up +0.10 +0.25%
Fresenius Medical… CAPS Rating: *****
STJ $62.91 Down -1.09 -1.70%
St. Jude Medical,… CAPS Rating: *****